TELANGIECTASIA, HEREDITARY HEMORRHAGIC
Clinical trials for TELANGIECTASIA, HEREDITARY HEMORRHAGIC explained in plain language.
Never miss a new study
Get alerted when new TELANGIECTASIA, HEREDITARY HEMORRHAGIC trials appear
Sign up with your email to follow new studies for TELANGIECTASIA, HEREDITARY HEMORRHAGIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a cancer drug spray stop debilitating nosebleeds?
Disease control CompletedThis trial tests whether a nasal spray containing bevacizumab, a drug typically used for cancer, can reduce frequent nosebleeds in people with hereditary hemorrhagic telangiectasia (HHT). The study enrolls 20 adults who have at least 10 nosebleeds per month. The goal is to see if…
Matched conditions: TELANGIECTASIA, HEREDITARY HEMORRHAGIC
Phase: PHASE1, PHASE2 • Sponsor: University Hospital, Caen • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
New ultra-low dose CT could slash radiation for HHT lung checks
Diagnosis CompletedThis study tested whether an ultra-low dose chest CT scan can find lung blood vessel malformations in people with hereditary hemorrhagic telangiectasia (HHT) as well as the standard low-dose CT scan, but with much less radiation. 45 HHT patients received both scans, and radiologi…
Matched conditions: TELANGIECTASIA, HEREDITARY HEMORRHAGIC
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Diagnosis
Last updated Jun 26, 2026 15:38 UTC